| Combined pulmonary fibrosis and emphysema in a smoker with apparently normal lung volumes C Sorino, S Agati, S Elia, G Melone, V Cottin Rare and Interstitial Lung Diseases, 81-94, 2025 | | 2025 |
| Evidence from recent clinical trials in fibrotic interstitial lung diseases V Cottin, C Valenzuela Current Opinion in Pulmonary Medicine 30 (5), 484-493, 2024 | 1 | 2024 |
| Outcomes of lung transplantation for pleuroparenchymal fibroelastosis: a French multicentric retrospective study H Clermidy, O Mercier, G Brioude, P Mordant, G Fadel, C Picard, ... The Journal of Heart and Lung Transplantation, 2024 | | 2024 |
| Donor to recipient age matching in lung transplantation: a European experience P Pradere, J Le Pavec, S Morisset, V Gerovasili, R Kessler, A Adlakha, ... The Journal of Heart and Lung Transplantation, 2024 | | 2024 |
| Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Study L Lancaster, V Cottin, M Ramaswamy, WA Wuyts, RG Jenkins, ... American Journal of Respiratory and Critical Care Medicine, 2024 | 2 | 2024 |
| POS0337 MEPOLIZUMAB VERSUS BENRALIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A EUROPEAN REAL-LIFE RETROSPECTIVE COMPARATIVE STUDY I Mattioli, A Bettiol, V Cottin, A Egan, F Franceschini, M Groh, DRW Jayne, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 390-391, 2024 | | 2024 |
| POS0593 CONTRIBUTION OF RARE EXONIC VARIANTS IN TELOMERE-RELATED GENES TO INTERSTITIAL LUNG DISEASE RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS AND IDIOPATHIC PULMONARY FIBROSIS PA Juge, L Kawano-Dourado, A Stockwell, JS Lee, S Gazal, G Mcdermott, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 807-808, 2024 | | 2024 |
| Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis R Diesler, V Cottin, Y Gallien, S Turquier, J Traclet, K Ahmad, JC Glerant Respiratory Medicine and Research 85, 101071, 2024 | | 2024 |
| Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors S Sidali, R Borie, FS De Fontbrune, K El Husseini, PE Rautou, E Lainey, ... Hepatology 79 (6), 1365-1380, 2024 | 6 | 2024 |
| Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension S Turquier, L Huot, M Lamkhioued, F Subtil, J Traclet, K Ahmad, F Lestelle, ... Plos one 19 (5), e0298727, 2024 | | 2024 |
| Zinpentraxin alfa in patients with idiopathic pulmonary fibrosis: results and learnings from the phase III STARSCAPE trial L Richeldi, C Schiffman, J Behr, Y Inoue, TJ Corte, V Cottin, RG Jenkins, ... presentation at: American Thoracic Society Meeting, 2024 | 1 | 2024 |
| Interstitial Lung Disease Associated with Systemic Sclerosis V Mismetti, S Si-Mohamed, V Cottin Seminars in Respiratory and Critical Care Medicine, 2024 | 1 | 2024 |
| Using Imaging to Predict, Identify, and Monitor Progression of Interstitial Lung Disease: Consensus Findings From a Modified Delphi Study S Walsh, AU Wells, KK Brown, A Adegunsoye, V Cottin, S Danoff, ... B46. UP AND COMING: ILD BIOMARKERS, A3703-A3703, 2024 | | 2024 |
| Baseline Characteristics of Patients Enrolled in FIBRONEER™-IPF, A Phase III Randomized Placebo-controlled Trial of the Preferential PDE4B Inhibitor Nerandomilast (BI 1015550 … L Richeldi, S Assassi, A Azuma, V Cottin, AM Hoffmann-Vold, M Kreuter, ... A32. BENCH TO BEDSIDE IN ILD, A1318-A1318, 2024 | | 2024 |
| TETON Phase 3 Clinical Trials of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis: Annual Update of Preliminary Baseline Data SD Nathan, J Behr, V Cottin, LH Lancaster, PM Smith, Y Rao, ... B48. NEW TREATMENTS IN DIFFUSE PARENCHYMAL LUNG DISEASE, A3759-A3759, 2024 | | 2024 |
| Study Design and Rationale for the TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis SD Nathan, J Behr, V Cottin, LH Lancaster, P Smith, Y Rao, ... B48. NEW TREATMENTS IN DIFFUSE PARENCHYMAL LUNG DISEASE, A3760-A3760, 2024 | | 2024 |
| Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH): An International Case Series M Penugonda, M O'Callaghan, R Diesler, H O'Brien, H Almeamar, ... C72. CASE REPORTS IN RESPIRATORY STRUCTURE AND FUNCTION, A6417-A6417, 2024 | | 2024 |
| How Should Patients With Progressive Pulmonary Fibrosis Be Identified? Consensus Findings From a Modified Delphi Study AU Wells, SLF Walsh, A Adegunsoye, V Cottin, S Danoff, A Devaraj, ... D92. BOOKENDS: ILAS TO PPF, A7217-A7217, 2024 | | 2024 |
| High risk of lung cancer in surfactant-related gene variant carriers A Brudon, M Legendre, A Mageau, J Bermudez, P Bonniaud, D Bouvry, ... European Respiratory Journal 63 (5), 2024 | | 2024 |
| Zinpentraxin alfa for idiopathic pulmonary fibrosis: the randomized phase III STARSCAPE trial L Richeldi, C Schiffman, J Behr, Y Inoue, TJ Corte, V Cottin, RG Jenkins, ... American Journal of Respiratory and Critical Care Medicine 209 (9), 1132-1140, 2024 | 10 | 2024 |
Bruno Crestaniuniversité paris diderotVerified email at bch.aphp.fr
